Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Brand Name :
Adrenalin, EpiPen, Auvi-Q, EpiPen Jr, Symjepi
Synonyms :
epinephrine
Class :
Alpha/ Beta Adrenergic Agonists; Alpha/ Beta Agonists
Dosage forms& StrengthsÂ
Syringe Â
0.3mg/0.3ml Â
Injectable (solution)Â
1mg/10mlÂ
1mg/mlÂ
Intravenous
0.5 to 1 mg intravenous injection as a single dose; while resuscitating, 0.5 mg should be administered intravenously every 5 minutes.
Endotracheal tube
Administer 2 to 2.5 mg through the endotracheal tube directly into the bronchial tree every 3 to 5 minutes.
Intracardiac
Administer 0.3 to 0.5 mg through intracardial injection into the left ventricular chamber as a one-time dose.
0.1 mg/ml solution
Administer 0.1 mg via intravenous route within 5 minutes at a pace of 1 to 4 mcg/minute to decrease the need for frequent injection dose
1 mg/ml solution
Administer an undiluted drug of 0.3 to 0.5 mg via intramuscular or subcutaneous injection into the front and outer part of the thigh.
Repeat the process every 5 to 10 minutes as required.
prefilled autoinjector or syringe
Administer 0.3 mg intramuscularly or subcutaneously into the front and outer part of the thigh and repeat for 5 to 15 minutes, as necessary.
Administer intravenous infusion at a rate of 0.05 to 2 mcg/kg/minute and adjust as necessary to attain the targeted mean arterial pressure (MAP). The dosage may be modified at regular intervals, for every 10 to 15 minutes, in increments of 0.05 to 0.2 mcg/kg/minute to achieve the desired blood pressure objective.
Dosage Forms & Strengths  Â
Prefilled autoinjector Â
0.1mg/0.1ml Â
0.15mg/0.15ml Â
0.3mg/0.3mlÂ
Injectable (solution)Â
1mg/10mlÂ
1mg/mlÂ
<30 kg weight:
Administer 0.01 mg/kg of the medication via intramuscular or subcutaneous injection into the front and outer area of the thigh and maximum dose not more than 0.3 mg per vial.
Repeat the dosage every 5 to 10 minutes as required.
≥30 kg weight
Administer 0.3 to 0.5 mg of via intramuscular or subcutaneous injection in the anterolateral region of the thigh and maximum dose not more than 0.5 mg per vial
Repeat the process every 5 to 10 minutes as required.
Refer to adult dosingÂ
It may enhance QTc interval when combined with pentamidine
It may increase the arrhythmogenic effect when combined with epinephrine (Systemic)
It may increase the arrhythmogenic effect when combined with epinephrine (Systemic)
It may increase the arrhythmogenic effect when combined with epinephrine (Systemic)
It may increase the arrhythmogenic effect when combined with epinephrine (Systemic)
It may increase the arrhythmogenic effect when combined with epinephrine (Systemic)
It may enhance QTc interval when combined with epinephrine
It may enhance QTc interval when combined with epinephrine
It may enhance QTc interval when combined with epinephrine
It may enhance the effects when combined with epinephrine by pharmacodynamic synergism
It may enhance the effects when combined with epinephrine by pharmacodynamic synergism
It may enhance the effects when combined with epinephrine by pharmacodynamic synergism
It may decrease the vasoconstricting effect when combined with epinephrine (Systemic)
It may enhance QTc interval when combined with perphenazine
may increase the hypertensive effect of Monoamine Oxidase Inhibitors
It may increase the hypertensive effect when combined with epinephrine (Systemic)
It may increase the hypertensive effect when combined with epinephrine (Systemic)
It may increase the hypertensive effect when combined with epinephrine (Systemic)
It may increase the hypertensive effect when combined with epinephrine (Systemic)
It may increase the hypertensive effect when combined with epinephrine (Systemic)
epinephrine: they may decrease the therapeutic effect of Beta-Blockers
When epinephrine is used together with mebhydrolin, epinephrine’s therapeutic effectiveness can be enhanced
When alprazolam and epinephrine is used together, this leads to reduction in the alprazolam’s metabolism
It may decrease the therapeutic effect when combined with epinephrine (Systemic)
the efficacy of benzylpenicillolyl polylysine as a diagnostic agent may be decreased with epinephrine
the therapeutic effect of epinephrine may be increased
Actions and spectrum:Â
Epinephrine is a sympathomimetic catecholamine, which interacts with both alpha and beta-adrenergic receptors through a G protein-linked second messenger system. It has the maximum affinity to G-protein coupled receptors at low levels, but at higher concentrations, it shows a preference for the alpha-1 receptors. Activation of alpha-1 adrenergic receptors by epinephrine causes an increase in contraction of vascular smooth muscle, pupillary dilator muscle, and intestinal sphincter muscle. Among the most evident of the changes in the chemical balance are the efficiently increased breathing rate, acceleration of the myocardial contraction, and the transformation of the angiotensinogen into angiotensin II. Bronchodilation from beta-2 receptors makes asthma treatment easier, but these medications can also cause symptoms such as vasodilation, tocolysis, and fluid buildup of the aqueous humor.Â
Adverse reactionsÂ
AnginaÂ
FlushingÂ
DizzinessÂ
PallorÂ
Respiratory difficultiesÂ
ApprehensivenessÂ
HeadacheÂ
NervousnessÂ
VomitingÂ
WeaknessÂ
SweatingÂ
TachycardiaÂ
RestlessnessÂ
PalpitationsÂ
Cardiac arrhythmiasÂ
DyspneaÂ
Stress cardiomyopathyÂ
TremorÂ
VasoconstrictionÂ
NauseaÂ
Post marketing reportsÂ
ArrhythmiasÂ
Reduced blood flow to hands, feet Â
Necrotizing fasciitis and myonecrosisÂ
Black box warningÂ
It may worsen the symptoms in patients with Parkinson’s diseaseÂ
Contraindications/CautionÂ
ContraindicationsÂ
Narrow- angle glaucomaÂ
LaborÂ
Increased maternal blood pressure i.e., 130/80mm of HgÂ
Concomitant administration of cyclopropane or halogenated hydrocarbonsÂ
Non anaphylactic shockÂ
CautionsÂ
Cardiac diseaseÂ
Pulmonary edemaÂ
Reduced urine output may be caused due to constriction of renal blood vesselÂ
Parkinson’s diseaseÂ
HypertensionÂ
Thyroid diseaseÂ
Diabetes mellitusÂ
PregnancyÂ
Prostatic hypertrophyÂ
History of hospitalization due to asthmaÂ
Geriatric patientsÂ
Cerebrovascular hemorrhageÂ
Death may happen due to rapid intravenous administrationÂ
Pregnancy & breastfeeding:Â
Pregnancy consideration:Â
USFDA pregnancy category: CÂ
Breastfeeding warnings:Â
Data about the excretion of the drug into human milk is not known.Â
Pregnancy category:Â
Pharmacology:Â
Epinephrine is also called as adrenaline. It is a neurotransmitter and a hormone produced by adrenal glands. Â
Pharmacodynamics:Â
Epinephrine is a drug that increases heart rate, myocardial contractility, and renin secretion through the activation of the beta-1 receptors. Furthermore, it also causes the activation of beta-2 receptor resulting in bronchodilation, reduction in uterine contractions, vasodilation, and elevated aqueous humor production. Â
Pharmacokinetics:Â
Absorption:Â
The onset of action is rapid when administered as an intravenous, subcutaneous or as an intramuscular injection. SC administration may give bronchodilation effect in 5 to 10 minutes with maximum effect being observed in 20 minutes.Â
Metabolism:Â
It undergoes enzymic transformation to normetanephrine or metanephrine, any of these would be conjugated to form glucuronides and sulfates. Mostly catechol-O-methyltransferase (COMT), and MAO (monoamine oxidase) rapidly inactivates epinephrine in the body. Its metabolites are sulfate conjugates, metadrenaline and inactive hydroxy derivative of mandelic acid.Â
Excretion:Â
Most of the drug is known to be eliminated through urine. About 40% of the parent drug is eliminated as metanephrine, 40% as vanillyl mandelic acid, 2% as 3,4-dihdroxymandelic acid, and 7% as 3-methoxy-4-hydroxyphenoglycol.Â
Half-life:Â
Two to three minutesÂ
Administration:Â
Depending on the diagnosis of condition, the drug can be administered in various forms.Â
In case of anaphylaxis, it is administered as an intramuscular injection into the anterolateral thigh due to its rapid absorption.Â
For ACLS (advanced cardiovascular life support), it can be given intraosseously or intravenously depending on the necessity. Â
For neonatal resuscitation, it can be administered through an endotracheal tube.Â
Patient information leafletÂ
Generic Name: epinephrineÂ
Why do we use epinephrine?Â
In the treatment of anaphylactic reactions, the drug is used as a first line of choice. It also alleviates symptoms such as swelling, hives, and breathing difficulties. In the therapy of cardiac arrest, it is indicated to raise the blood pressure and restore circulation. It also acts as a vasopressor and helps to maintain the flow of blood to vital organs. In severe episodes of asthma, epinephrine is administered to open airways and improve breathing.Â